【先声全重发布“求索计划”：将持续5年投入累计20亿元，针对10大研究方向】金十数据3月29日讯，3月29日，神经与肿瘤药物研发全国重点实验室协同创新会议期间，先声全重“求索计划”正式发布。求索计划由11位中国科学院及工程院院士组成科学指导委员会为项目进行方向性规划，支持神经与肿瘤药物研发领域从0到1的颠覆性创新。根据会议现场发布的细则显示，求索计划将持续5年投入累计20亿元，针对10大研究方向，鼓励非共识性创新、多学科交叉融合、综合运用新兴技术，探索和创造伟大的、前所未有的治疗手段。神经与肿瘤药物研发全国重点实验室依托先声药业和先声诊断建设，2015 年获科技部批准建设“转化医学与创新药物国家重点实验室”，2021 年正式通过国家五年建设期验收，2023年通过重组验收并更名。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.